Here's what Houston hospitals ranked as best in the nation this year

best of the rest

U.S. News & World Report has released its annual and much-heralded list of Best Hospitals in the nation. Photo courtesy

A prestigious, annual national report has verified what Houstonians already know: Our Medical Center boasts the best adult and children’s hospital in Texas and the best cancer center in America.

U.S. News & World Report released its 2022-23 Best Hospitals list, which names The University of Texas MD Anderson Cancer Center No. 1 in the nation for cancer care. For those keeping track, MD Anderson has been considered in the top two cancer hospitals in the U.S. since the U.S. News launched the survey in 1990.

While securing the top rank for cancer care, MD Anderson also scored high national ranks for specialty treatments: urology (No. 5) and diabetes and endocrinology (No. 13). The center continues to maintain its “High Performing” rating on the U.S. News list for colon cancer and lung cancer. It also received “High Performing” ratings for the three newly added adult procedures and conditions: ovarian cancer, prostate cancer, and uterine cancer, per a press release.

“We are proud to be ranked as the nation’s leader in cancer care,” said Peter WT Pisters, M.D., president of MD Anderson, in a statement. “This ongoing recognition is thanks to the incredible MD Anderson community, including our faculty, employees, trainees, students, donors and advocates, who advance our science and our mission and who serve our patients by enabling us to provide the best care possible.”

Rankings for the annual U.S. News study are based on scores in patient care, patient safety, outcomes, nursing, advanced technology, and reputation.

Houston leads medicine in Texas
The tagline for Houston Methodist Hospital systems — “leading medicine” — is quite fitting here in Texas. The hospital comes in at No. 15 nationally (marking the sixth time it has been recognized in the report’s Honor Roll) and No. 1 in Texas for the 11th year in a row. Locally, Houston Methodist Sugar Land ranks No. 5 in Houston and No. in Texas, a press release notes.

Notably, U.S. News has ranked Houston Methodist Hospital in at least one specialty for the past 30 years. This year, Houston Methodist Hospital ranks in 10 specialties, the most of any hospital in the state, according to the report. Two of these ranked specialties appear in the list’s top 10 (diabetes and endocrinology at No. 9; gastroenterology/GI surgery at No. 8), while six are ranked in the top 20.

“This is a tremendous achievement for our physicians and employees who dedicate themselves every day to our patients – especially as we continue to provide the highest quality care during these trying times in health care,” said Marc Boom, M.D., president and CEO of Houston Methodist, in a statement. “Our mission to provide unparalleled care is for our patients, who are the reason we need to be one of the best hospital systems in the country.”

Texas Children’s tops Texas and Southwest
Yet another Houston hospital scored extremely well nationally in the list. Texas Children’s Hospital ranks No. 2 overall in the Best Children’s Hospitals ranking. The beloved children’s center also remains top in Texas and the Southwest, and at No. 1 in heart treatment for the sixth year in a row. No other pediatric hospital in Texas has achieved an overall ranking as high as Texas Children’s has in the past 14 years, a Texas Children’s release notes.

“We are beyond thrilled with the newest U.S. News & World Report rankings that place Texas Children’s Hospital second in the United States and first in the state of Texas,” said Mark A. Wallace, president and CEO, in a statement. “Consistent collaboration, newfound discoveries and extraordinary patient care is what has brought us to where we are today. I am incredibly proud of this remarkable team and everything we’ve accomplished together — and our promise to every family is that we are just getting started.”

Texas’ best mental health care is here
Also boasting top honors in the state — and No. 10 nationally — is the Menninger Clinic. The acclaimed facility tied for tenth place on U.S. News’ list of best psychiatric hospitals, making it the all-out best in Texas.

Of note, Menninger has been named a top-10 psychiatry hospital in the U.S. for 32 consecutive years, the hospital points out. “With the growing need for mental health care, we are grateful for the trust that psychiatrists have had in referring their clients to The Menninger Clinic for comprehensive diagnosis and treatment,” said president and CEO Armando E. Colombo in a statement.

Elsewhere in Texas
Dallas-Fort Worth is home to the No. 2 hospital in Texas, per U.S. News. UT Southwestern Medical Center in Dallas also ranked especially well nationally in urology (No. 11), cardiology and heart surgery (No. 14), diabetes and endocrinology (No. 18), pulmonology and lung surgery, (No. 21), and cancer (No. 25).

Not far down the list is Baylor University Medical Center in Dallas, which ranked No. 4 in Texas. One Baylor department ranked nationally: gastroenterology and GI surgery department, No. 34.

Meanwhile, Austin’s St. David’s Medical Center ranked No. 8 in Texas. Austinites in need of post-procedure work and physical therapy should note that the hospital’s rehabilitation department ranked nationally, coming in at No. 37 overall.

------

This article originally ran on CultureMap.

From Your Site Articles
Through a $4 million grant, the city of Houston will be able to provide mental health treatment to at-risk students. Educational First Steps/Facebook

City of Houston and local health care organizations receive $4M to treat mental health in students

Help granted

The city of Houston just received a major opportunity to help grow access to mental health treatment in children.

Thanks to a four-year $4 million grant from the United States Substance Abuse and Mental Health Services Administration, the city and its partner, Baylor College of Medicine, are launching the Be-Well Be-Connected program that provides at-risk students age six to 17 years old with mental health treatment.

The program will be led by Dr. Laurel Williams, associate professor of psychiatry at Baylor, division head for child and adolescent psychiatry and chief of psychiatry at Texas Children's Hospital. The treatment will include cognitive behavioral intervention for students with bipolar disorder and first episode psychosis, according to the release. The services will be provided in the child's home, which will ensure compliance.

"We do not have many places in Houston that have this capability to provide this level of intensity of services," Williams says in the release. "Having in-home therapy can allow the young person to stay engaged in their community and in their schools, which can promote wellness and reduction in symptoms burden more quickly."

Other Houston health centers, including Texas Children's Hospital, Harris Health System, Menninger Clinic, Harris Center, Veteran's Mental Health Care Line, Legacy Community Health Services, and DePelchin's Children's Center, will be involved with the program and the Mayor's Office of Education is the program manager of the grant.

"I created the Office of Education to support school districts in Houston because they are doing the essential work of guaranteeing that our next generation of adults is educated and ready for the future," says Mayor Sylvester Turner in the release. "The grant validates our efforts and more importantly will provide care on the frontlines of a key health issue involving young people."

Five independent school districts will also receive first level screening services and telemedical care. Families of the students receiving care will also receive support from the newly developed Texas State Child Mental Health Consortium.

"Houston and our surrounding area is primed to really take children's mental health care to the next needed level," says Williams in the release. "This SAMHSA grant opportunity coupled with the State Consortium will allow better coordination amongst services and an overall increase in available services — services that are desperately needed."

Houston Methodist Hospital once again lands on U.S. News & World Report's "Honor Roll." Courtesy of Methodist Hospital/Facebook

2 Houston hospitals honored among America's best in prestigious report

What the Doctor Ordered

Houston's Medical Center is often described as the epicenter of innovation and treatment in the U.S. — as well as the site of Nobel Prize-winning work. Now, a new report offers more bragging rights for the beloved center, as two of its hospitals have landed on a coveted list of the best facilities in the nation.

U.S. News & World Report has released its 2019-2020 list of best hospitals, citing Houston Methodist Hospital and The Menninger Clinic among the top in America.

The publication named Houston Methodist Hospital to its Honor Roll, a list of the top 20 hospitals in the country. Methodist tied for No. 20 with Yale New Haven Hospital in Connecticut, Mayo Clinic-Phoenix, and Hospitals of the University of Pennsylvania-Penn Presbyterian in Philadelphia.

To determine the Honor Roll, U.S. News ranks hospital performance in 16 areas of complex specialty care and rates hospitals in nine bellwether procedures and conditions, such as heart bypass, hip and knee replacement, heart failure, and lung cancer surgery, the publication notes.

This is the third time Methodist has secured the Honor Roll and the eighth year in a row it has been named the No. 1 hospital in Texas. Methodist also ranked No. 1 in the Gulf Coast region and was awarded national rankings in nine adult specialties and recognized as "high performing" for nine adult procedures and conditions.

Meanwhile, in the nationwide survey, The Menninger Clinic ranked No. 5 overall among Best Hospitals for Psychiatry. The institution, which offers treatment services for psychiatric disorders and substance abuse issues, has been ranked by U.S. News for 30 consecutive years, according to a release.

The report distinguishes the best hospitals for patients experiencing difficult-to-treat psychiatric disorders and is based on survey responses from 2017 to 2019 from physicians nationwide who are board certified in psychiatry, according to the publication.

During the three-year survey period, Menninger treated patients from all 50 states and 18 countries through five specialty inpatient programs, says a release. The hospital assists patients ranging from adolescents to adult professionals and hosts a popular annual luncheon featuring a celebrity keynote speaker who has dealt with mental wellness issues.

------

This story originally appeared on CultureMap.com.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Texas space co. takes giant step toward lunar excavator deployment

Out of this world

Lunar exploration and development are currently hampered by the fact that the moon is largely devoid of necessary infrastructure, like spaceports. Such amenities need to be constructed remotely by autonomous vehicles, and making effective devices that can survive the harsh lunar surface long enough to complete construction projects is daunting.

Enter San Antonio-based Astroport Space Technologies. Founded in San Antonio in 2020, the company has become a major part of building plans beyond Earth, via its prototype excavator, and in early February, it completed an important field test of its new lunar excavator.

The new excavator is designed to function with California-based Astrolab's Flexible Logistics and Exploration (FLEX) rover, a highly modular vehicle that will perform a variety of functions on the surface of the moon.

In a recent demo, the Astroport prototype excavator successfully integrated with FLEX and proceeded to dig in a simulated lunar surface. The excavator collected an average of 207 lbs (94kg) of regolith (lunar surface dust) in just 3.5 minutes. It will need that speed to move the estimated 3,723 tons (3,378 tonnes) of regolith needed for a lunar spaceport.

After the successful test, both Astroport and Astrolab expressed confidence that the excavator was ready for deployment. "Leading with this successful excavator demo proves that our technology is no longer theoretical—it is operational," said Sam Ximenes, CEO of Astroport.

"This is the first of many implements in development that will turn Astrolab's FLEX rover into the 'Swiss Army Knife' of lunar construction. To meet the infrastructure needs of the emerging lunar economy, we must build the 'Port' before the 'Ship' arrives. By leveraging the FLEX platform, we are providing the Space Force, NASA, and commercial partners with a 'Shovel-Ready' construction capability to secure the lunar high ground."

"We are excited to provide the mobility backbone for Astroport's groundbreaking construction technology," said Jaret Matthews, CEO of Astrolab, in a release. "Astrolab is dedicated to establishing a viable lunar ecosystem. By combining our FLEX rover's versatility with Astroport's civil engineering expertise, we are delivering the essential capabilities required for a sustainable lunar economy."

---

This article originally appeared on CultureMap.com.

Houston biotech co. raises $11M to advance ALS drug development

drug money

Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment round.

India-based pharmaceuticals company Dr. Reddy’s Laboratories Inc. led the round with a $10 million investment, according to a news release. New York-based investment firm Greenlight Capital, Coya’s largest institutional shareholder, contributed $1.1 million.

The funding was raised through a definitive securities purchase agreement for the purchase and sale of more than 2.5 million shares of Coya's common stock in a private placement at $4.40 per share.

Coya reports that it plans to use the proceeds to scale up manufacturing of low-dose interleukin-2 (IL-2), which is a component of its COYA 302 and will support the commercial readiness of the drug. COYA 302 enhances anti-inflammatory T cell function and suppresses harmful immune activity for treatment of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s disease and Alzheimer’s disease.

The company received FDA acceptance for its investigational new drug application for COYA 302 for treating ALS and FTD this summer. Its ALSTARS Phase 2 clinical trial for ALS treatment launched this fall in the U.S. and Canada and has begun enrolling and dosing patients. Coya CEO Arun Swaminathan said in a letter to investors that the company also plans to advance its clinical programs for the drug for FTD therapy in 2026.

Coya was founded in 2021. The company merged with Nicoya Health Inc. in 2020 and raised $10 million in its series A the same year. It closed its IPO in January 2023 for more than $15 million. Its therapeutics uses innovative work from Houston Methodist's Dr. Stanley H. Appel.

New accelerator for AI startups to launch at Houston's Ion this spring

The Collectiv Foundation and Rice University have established a sports, health and wellness startup accelerator at the Ion District’s Collectiv, a sports-focused venture capital platform.

The AI Native Dual-Use Sports, Health & Wellness Accelerator, scheduled to formally launch in March, will back early-stage startups developing AI for the sports, health and wellness markets. Accelerator participants will gain access to a host of opportunities with:

  • Mentors
  • Advisers
  • Pro sports teams and leagues
  • University athletics programs
  • Health care systems
  • Corporate partners
  • VC firms
  • Pilot projects
  • University-based entrepreneurship and business initiatives

Accelerator participants will focus on sports tech verticals inlcuding performance and health, fan experience and media platforms, data and analytics, and infrastructure.

“Houston is quickly becoming one of the most important innovation hubs at the intersection of sports, health, and AI,” Ashley DeWalt, co-founder and managing partner of The Collectiv and founder of The Collectiv Foundation, said in a news release.

“By launching this platform with Rice University in the Ion District,” he added, “we are building a category-defining acceleration engine that gives founders access to world-class research, global sports properties, hospital systems, and venture capital. This is about turning sports-validated technology into globally scalable companies at a moment when the world’s attention is converging on Houston ahead of the 2026 World Cup.”

The Collectiv accelerator will draw on expertise from organizations such as the Rice-Houston Methodist Center for Human Performance, Rice Brain Institute, Rice Gateway Project and the Texas Medical Center.

“The combination of Rice University’s research leadership, Houston’s unmatched health ecosystem, and The Collectiv’s operator-driven investment platform creates a powerful acceleration engine,” Blair Garrou, co-founder and managing partner of the Mercury Fund VC firm and a senior adviser for The Collectiv, added in the release.

Additional details on programming, partners and application timelines are expected to be announced in the coming weeks.

View All Listings